|
EPT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.217500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.007000E-04 |
| Normal-vs-Stage2 |
7.865600E-02 |
| Normal-vs-Stage3 |
4.554600E-04 |
| Normal-vs-Stage4 |
5.242600E-04 |
| Stage1-vs-Stage2 |
4.383400E-01 |
| Stage1-vs-Stage3 |
4.740800E-01 |
| Stage1-vs-Stage4 |
4.451400E-01 |
| Stage2-vs-Stage3 |
2.614800E-01 |
| Stage2-vs-Stage4 |
2.526400E-01 |
| Stage3-vs-Stage4 |
8.477200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.224200E-04 |
| Normal-vs-AfricanAmerican |
9.927700E-02 |
| Normal-vs-Asian |
9.70070000000378E-05 |
| Caucasian-vs-AfricanAmerican |
4.093800E-01 |
| Caucasian-vs-Asian |
2.653200E-01 |
| AfricanAmerican-vs-Asian |
1.136010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.150460E-04 |
| Normal-vs-Female |
1.496730E-03 |
| Male-vs-Female |
9.273600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.042780E-03 |
| Normal-vs-Age(41-60Yrs) |
5.406700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.900400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.809430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.627000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.952800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.491000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.630400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.253600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.303600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.871900E-02 |
| Classical-VS-Follicular |
7.178400E-01 |
| Classical-VS-Other |
9.535600E-02 |
| Classical-VS-Normal |
2.360100E-03 |
| Tall-VS-Follicular |
3.036400E-01 |
| Tall-VS-Other |
2.231800E-01 |
| Tall-VS-Normal |
6.760000E-04 |
| Follicular-VS-Other |
2.128800E-01 |
| Follicular-VS-Normal |
6.603600E-03 |
| Other-VS-Normal |
3.979200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.455030E-03 |
| Normal-vs-N1 |
1.58019999996206E-06 |
| N0-vs-N1 |
3.464400E-02 |
|
|
